Scientists at the West Virginia University Rockefeller Neuroscience Institute hope to unlock the true potential of drugs designed to target Alzheimer's.

A new analysis of classical medical texts suggests dementia was extremely rare in ancient Greece and Rome 2,000 to 2,500 ...

Steve Waddell, the founder, president and CEO of Nasoni, recently landed a $2.58 million federal grant to integrate advanced ...

Subtle changes in brain activity in the presence of both amyloid-beta and tau proteins may point to Alzheimer's disease, long ...

Lutheran Home invites the community to discover the art of positive aging at ThriveFEST 2024, celebrating life, learning and ...

The event will also feature raffles, giveaways and a “Sharing Space,” where caregivers can leave their own written tips or ...

Japan, with its rapidly aging population, is expected to have more than 5 million patients with dementia by 2030. Alzheimer’s ...

The Dutch company has created a device for the early detection of Alzheimer’s disease, and it is on its way to developing ...

(RTTNews) - Eli Lilly and Company (LLY) Tuesday said its Kisunla for the treatment of adults with early symptomatic Alzheimer's disease has been approved by the Ministry of Health, Labour and Welfare ...

Eli Lilly on Tuesday said Japan's Ministry of Health, Labour and Welfare Japan approved Kisunla for adults with early symptomatic Alzheimer's, including those with mild cognitive impairment as well as ...

Eli Lilly’s (NYSE:LLY) treatment for early Alzheimer's disease has been approved for use in Japan. Kisunla (donanemab-azbt), ...

Eli Lilly said on Tuesday Japan's health ministry has approved donanemab, its drug for Alzheimer's disease, providing ...